secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2026-04-07T23:59:59+00:00
Accession:  0001372514-26-000036
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora Pharmaceuticals closes $5M private placement with Perceptive Advisors; warrants could add $19M
--------------------------------------------------------------------------------

- Closed private placement raising $5.0M upfront; potential $19M from warrant exercise.
- Sole investors: Perceptive Advisors and ADAR1 Capital Management; no placement agent engaged.
- Each unit: 1 common share (or pre-funded warrant) + 4 Tranche A-1 + 1 Tranche A-2 warrants at $2.543.
- All warrants exercisable at $1.94/share; A-1 term ≤9 months (30 days after strategic transaction), A-2 ≤4 years (30 days after Phase 3 enrollment).
- Proceeds for general corporate purposes, including R&D and business development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/0001372514-26-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251426000036/kprx-20260403.htm
  HTML page:      https://secwatch.observer/filing/0001372514-26-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer